TREM2 and Alzheimer disease: Chan et al., reported that a polymorphism of TREM1 leads to increased AD pathology and cognitive decline by raising the cell surface expression levels of the anti-inflammatory TREM2 in younger but not in older individuals (Chan et al., 2015).